UNRESECTABLE COLORECTAL ADENOCARCINOMA
Clinical trials for UNRESECTABLE COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets metastatic colorectal cancer in early trial
Disease control Recruiting nowThis early-phase trial is testing whether adding an experimental drug called CA-4948 to standard chemotherapy (FOLFOX) and a targeted therapy (bevacizumab) is safe for people with metastatic colorectal cancer. About 24 adults whose cancer has spread and cannot be surgically remov…
Matched conditions: UNRESECTABLE COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New hope for Tough-to-Treat colorectal cancer: drug combo trial launches
Disease control Recruiting nowThis study tests two drugs, pidnarulex and cemiplimab, in people with advanced colorectal cancer that hasn't responded to standard treatments. The goal is to find the best dose and see if the combination can slow or stop cancer growth. About 86 adults with a specific type of colo…
Matched conditions: UNRESECTABLE COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC